Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
December 2016 onwards
Submit An Event
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
19 May 2014 - 20 May 2014
Method Development and Optimization for LC/MS/MS
19 May 2014 - 21 May 2014
PharmAccess Leaders Forum
19 May 2014 - 20 May 2014
Pharma & Biotech Finance Leaders Forum
20 May 2014 - 21 May 2014
GCP and Quality in Clinical Trials
21 May 2014 - 22 May 2014
Mass Spectral Interpretation
21 May 2014 - 21 May 2014
TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
22 May 2014 - 23 May 2014
Prague, Czech Republic
2 days Experimental design and statistical data analysis for qPCR
27 May 2014 - 27 May 2014
Using cloud based virtual screening to find novel leads
30 May 2014 - 30 May 2014
Amsterdam, The Netherlands
Oral Solid Dosage Manufacturing Technology
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,300+ scientific and medical posters
4,800+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!